Study of CD137 Agonist ADG106 With Advanced or Metastatic Solid Tumors and/or Non-Hodgkin Lymphoma
Clinical trial NCT03707093 · COMPLETED
Trial details
- NCT number
- NCT03707093
- Sponsor
- Adagene Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-17
- Primary completion
- 2022-01-24
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.